Pivotal phase III trial of ciprofloxacin 0.3% otic foam (FoamOtic Externa) in patients with acute otitis externa.
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Otitis externa
- Focus Registrational; Therapeutic Use
- Sponsors Novus Therapeutics; Otic Pharma
- 10 May 2017 According to Tokai Pharmaceuticals Media Release, Tokai Pharmaceuticals has merged with Otic Pharma and subsequently changed its name to Novus Therapeutics.
- 22 Jan 2015 New trial record